ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 25

$396K Total Retail Price of All Prescriptions

Rank: 9 out of 25

234 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 234 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 234 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 8,639 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 27.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 439 435 1 2
OMEPRAZOLE 398 376 2 5
WARFARIN SODIUM 366 326 3 8
SIMVASTATIN 294 283 4 1
AMLODIPINE BESYLATE 253 244 5 7
DONEPEZIL HCL 222 222 6 11
ALENDRONATE SODIUM 203 203 7 18
METOPROLOL TARTRATE 198 178 8 9
HYDROCODONE-ACETAMINOPHEN 197 191 S3 9 6
SERTRALINE HCL 187 179 10 16
LISINOPRIL 180 180 11 4
METOPROLOL SUCCINATE 173 173 12 14
FUROSEMIDE 172 167 13 3
CITALOPRAM HBR 160 160 14 20
MIRTAZAPINE 116 116 15 26
PRAVASTATIN SODIUM 114 111 16 44
POTASSIUM CHLORIDE 110 107 17 15
HYDROCHLOROTHIAZIDE 100 100 18 17
TAMSULOSIN HCL 99 98 19 27
CLOPIDOGREL 94 94 20 29
POLYETHYLENE GLYCOL 3350 93 93 21 23
GABAPENTIN 86 75 22 12
TRAMADOL HCL 86 86 22 13
ENALAPRIL MALEATE 83 78 24 30
ATENOLOL 81 81 25 31
OXYBUTYNIN CHLORIDE ER 80 80 26 46
LIDODERM 76 75 27 64
ATORVASTATIN CALCIUM 74 74 28 24
FAMOTIDINE 72 72 29 38
PLAVIX 68 68 30 51
FLUTICASONE PROPIONATE 65 65 31 47
LEVOFLOXACIN 63 62 32 56
KLOR-CON M20 63 58 32 49
ALBUTEROL SULFATE 62 62 34 94
CARVEDILOL 60 56 35 28
IPRATROPIUM-ALBUTEROL 60 60 35 72
DIGOXIN 59 59 37 73
LOVASTATIN 59 59 37 82
DIOVAN 58 58 39 45
QUETIAPINE FUMARATE 58 58 39 35
PREDNISONE 57 57 41 41
NAMENDA 56 56 42 22
METFORMIN HCL 56 53 42 10
TORSEMIDE 55 46 44 188
CEPHALEXIN 54 54 45 136
BUMETANIDE 54 54 45 132
CARBIDOPA-LEVODOPA 51 51 47 50
TRAZODONE HCL 51 47 47 36
DILTIAZEM 24HR CD 50 50 49 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.